How to Get Multiple Offers for Your Veterinary Practice in 2026

Key takeaways

• Buyer-list quality over quantity; careful qualification matters more than the size of a contact list.
• Indications versus offers; price range, assumptions, structure, and conditions must become clear before proposals are comparable.
• Price and terms together; cash, retained equity, contingent payments, employment obligations, and tax allocation can change what a headline means.
• Current activity without certainty; 2026 pet-sector deal counts show buyers are transacting, but no market statistic promises an outcome.
• Evidence instead of guarantees; a process cannot promise a buyer count, valuation, timeline, or closing.

The number is never the whole question. I see the same scene over dinner: an owner sets competing proposals beside the salt shaker, and the higher headline comes wrapped in language that muddies the comparison.

The scene is a composite of conversations I have repeatedly, not a claim about one identifiable client.

Practice owners rarely receive neatly matched checks. They receive different assumptions, different structures, and different versions of what happens after the signature.

My first job is to slow the room down. Before we call anything “multiple offers,” we need to know whether the buyers are qualified and whether the proposals are actually comparable.

To pursue multiple offers, prepare defensible financials and screen prospective buyers for practice fit, apparent financial capacity, a workable ownership path, confidentiality discipline, and willingness to evaluate the specific veterinary practice.

Then disclose information in controlled stages and request comparable written proposals. This structure creates price-and-term discovery; it does not guarantee a buyer count, value, timetable, or closing.

What do “multiple offers” mean for a 2026 veterinary practice sale?

Multiple offers are developed written proposals from qualified buyers, with enough price, structure, assumptions, and conditions to compare.

A list of interested names, introductory calls, or preliminary indications does not meet that standard. A signed letter of intent still is not a completed sale.

Separate labels. Blurring them creates false confidence.

Stage	What it shows	What it does not show
Interested party	A buyer wants initial information	Capacity, fit, or willingness to propose terms
Qualified buyer	The buyer passed screening for practice fit, apparent financial capacity, a workable ownership path, confidentiality discipline, and willingness to evaluate the specific practice	A promise to bid or close
Indication of interest	A preliminary range, structure, and assumptions	A final or binding offer
Developed offer	Comparable written economic and non-economic terms	A completed diligence review or closing
Letter of intent	Principal terms selected for negotiation	Final documents, tax result, or certainty of closing

An indication of interest, often shortened to IOI, is a preliminary and non-binding view of possible price and structure. It is useful evidence, but it is not a finished offer.

A letter of intent, or LOI, records principal terms and can contain both binding and non-binding provisions. It comes before definitive documents, so transaction counsel should explain exactly what a signature changes.

This distinction protects the owner from counting enthusiasm as money. It also keeps the process honest when a proposal still depends on untested assumptions.

Why isn’t the biggest buyer list the goal in 2026?

The goal is not maximum exposure. Names alone are cheap evidence of fit.

A small, defensible field of qualified buyers is screened for practice fit, apparent financial capacity, a workable ownership path, confidentiality discipline, and willingness to evaluate the specific veterinary practice.

Wider outreach can increase confidentiality risk without producing a developed proposal.

The active buyer universe is not uniform. Capstone Partners counted 18 announced or completed pet-sector deals through April 10, 2026, compared with 8 in the prior-year period; veterinary and health led with 9.

Capstone also recorded 10 strategic transactions versus 3 in the prior-year period, plus 3 financial-sponsor platform deals and 5 add-ons. Those are sector counts, not a forecast for one practice.

Financial capacity varies too. Octus reported $3.1 billion in principal from publicly reporting credit vehicles to veterinary companies as of Q3 2025.

The same credit review put first-lien loan marks for one ownership model between 88% and 101.2% of par, averaging 97.4%.

I read that as a screening lesson, not a reason to predict any bidder’s behavior.

Fit matters because primary care remains a distinct lane. A 2025 peer-reviewed Frontiers analysis estimated that large groups owned about 25% of primary-care practices, compared with roughly 75% of specialty and emergency locations.

Transitions Elite’s intended client focus is the owner of a $2M-plus companion-animal general practice. The buyer list should be built around that actual practice, not every organization whose name appears in a directory.

That filter is the point of the Elite Selling System: we vet who gets inside, like a doorman admitting only the right people past a velvet rope.

It creates a controlled opportunity to compete, never a promise that anyone will.

What must be ready before buyers see a 2026 veterinary practice?

Before outreach, the owner needs repeatable earnings, documented adjustments, stable doctor coverage, and a coherent operating story.

Buyers can disagree about value, but they should not work from conflicting facts. Preparation makes proposals more comparable; it does not manufacture demand.

Start with normalized EBITDA. That means operating profit before taxes and accounting choices, adjusted for documented owner-specific or nonrecurring items so a buyer can examine repeatable earnings.

The adjustment file matters as much as the total. Each item needs a plain explanation and supporting record, because unsupported additions can make every later comparison less reliable.

Scale also needs context. AVMA reported that US veterinary practices averaged about $1.5 million in gross revenue in 2024, with 2.76 full-time-equivalent veterinarians and $554,982 of revenue per veterinarian.

Those are profession benchmarks, not a valuation formula. A $2M-plus practice can still have fragile earnings, and a buyer may view owner dependence, doctor stability, or growth quality differently.

The valuation literature makes that uncertainty visible. QuantPillar’s Q1 2026 synthesis of 900-plus private transactions placed veterinary practice EBITDA multiples across a broad 8x–14x range and called size the most predictable cross-industry driver.

Other publications frame different slices. Octus described practice-level acquisitions in the mid-to-high single digits, while iVET360 described 8x–13x for high-performing veterinary practices.

Those 3 attributed ranges cover different practice populations. None is an estimate for your practice.

That spread is why I would not price an owner’s life’s work from one published multiple.

Our veterinary practice valuation guide explains how earnings quality, scale, and risk interact before a buyer sees the page.

Profit quality is the anchor. Veterinary Practice News described a “no-lo” practice as one with no or low value, and identified missed charges and weak inventory controls among its observed profit leaks.

How does a confidential competitive process work in 2026?

A confidential process moves from preparation to screened outreach, staged disclosure, comparable indications, clarified offers, and LOI negotiation.

Identity and detailed records are released only as needed. Each stage narrows uncertainty while preserving alternatives, but no stage guarantees participation or completion.

The sequence I use is straightforward.

• Evidence preparation documents normalized earnings, doctor coverage, operating trends, real estate assumptions, and the questions a buyer will test.
• Buyer-universe screening tests practice fit, apparent financial capacity, a workable ownership path, confidentiality discipline, and willingness to evaluate the specific veterinary practice.
• Controlled staged disclosure begins anonymously, requires confidentiality protections, and releases identifying, financial, and operational details only to screened parties.
• Comparable indications ask interested buyers to state price range, structure, assumptions, and major conditions in a common format.
• Written-offer clarification resolves open assumptions and compares cash, contingent value, retained equity, employment terms, financing dependencies, and closing conditions.
• LOI negotiation uses evidence from qualified proposals to negotiate principal terms before entering a more restricted negotiation stage.

The owner’s guide to selling a veterinary practice covers the larger sale journey. Here, the discipline is narrower: give qualified buyers the same core facts, then record where their interpretations differ.

Confidentiality is managed risk. No magic seal.

Anonymous outreach, careful buyer selection, controlled access, and counsel-drafted protections can reduce exposure, but they cannot remove it.

I also avoid a fixed public timeline. Readiness, market response, diligence, financing, state rules, and document negotiation can all change the pace.

How should you distinguish IOIs, offers, and LOI terms in 2026?

Treat an IOI as preliminary evidence, an offer as a developed written proposal, and an LOI as principal terms chosen for deeper negotiation.

Compare what each document actually commits to. The label alone does not establish certainty, enforceability, or closing readiness.

An IOI may use a range and list assumptions. That can help identify serious interest, but it still leaves unanswered questions about structure, employment, financing, and diligence.

A developed offer should make those economics easier to compare. I want the buyer to state what is cash, what remains contingent, what the seller retains, and what facts could change the proposal.

The LOI is different because the owner is selecting a path. Before signature, counsel should identify exclusivity, access, confidentiality, expense, termination, and any other provisions that may be binding.

This is also where owner language matters. “Highest” describes one number; “strongest” requires a whole proposal.

If you already have an unsolicited approach, the sell-my-veterinary-practice decision guide can help separate curiosity, preparation, and an actual decision to enter a process.

How do you compare veterinary practice offers in 2026?

Put every developed proposal on one comparison grid: cash at closing, retained equity, contingent payments, tax allocation, employment terms, financing assumptions, and diligence conditions.

Then ask counsel and tax advisers to examine the buyer’s earnings definition, every assumption, and the full legal and after-tax consequences.

An earnout is value paid later only if agreed performance conditions are met. Rollover equity is ownership the seller retains in the buyer’s new entity instead of receiving that portion as cash at closing.

Neither is automatically good or bad. The questions are control, conditions, timing, information rights, transfer restrictions, and what happens if the post-closing plan changes.

Tax allocation belongs on the grid as well.

The IRS requires purchaser and seller to file Form 8594 for applicable asset acquisitions, allocating price across 7 asset classes, with Class VII covering goodwill and going-concern value.

That allocation can change the after-tax meaning of the same headline. It is why the tax adviser needs the actual proposal, not a number repeated in conversation.

Employment terms are another economic term. Schedule, compensation, clinical authority, restrictive provisions, and departure rights can carry more personal weight than a small difference in stated price.

Finally, record conditions. Financing, landlord approval, ownership structure, licensing, diligence, and documentation may all sit between a proposal and a closing.

What does the 2026 market say about offer strategy?

The 2026 evidence supports careful outreach, not certainty.

Pet-sector transactions increased early, yet veterinary data still shows price-driven revenue, falling visits, uneven profitability, and buyer-capacity differences. Practice quality and buyer capacity remain decisive for a specific companion-animal general practice during buyer screening.

The early deal count is constructive. Still, Capstone’s 18-versus-8 comparison covers the entire pet sector through April 10, not every veterinary practice and not the rest of the year.

Not certainty.

Practice operations remain mixed. Vetsource’s tracked panel of 6,412 practices, averaging $2.2 million in revenue, showed trailing revenue up 2.2% while visits fell 2.9% in October 2025.

AVMA’s February 2026 reporting told a similar story for 2025: visits fell roughly 3%, revenue rose about 2.5%, and only 32% reported improved profitability.

iVET360’s April 2026 benchmark announcement measured 2.6% revenue growth for 2025 while transaction volume fell 4.7%.

Its average transaction charge rose 7.5%, another sign that price, not patient volume, carried much of the growth.

For an owner, those trends make evidence more important. Buyers may ask whether revenue is supported by durable demand, doctor capacity, service mix, or repeated price increases.

The market also has future supply. Peer-reviewed 2024 research found planned clinical-work reductions among 61% of veterinarians within 5 years, while 31% planned to stop entirely; the mean expected retirement age was 64.

That finding does not predict how many practices will sell or when. It does argue against waiting for a demographic wave and assuming buyers will compete automatically.

What can a 2026 competitive process not promise?

A process cannot promise multiple offers, a particular value, a faster timetable, favorable bidder conduct, or a closing.

It can organize evidence, screen fit, create comparable requests, and preserve informed choices. The outcome still depends on the practice, market, buyers, terms, and diligence.

I say this plainly because “get multiple offers” can sound like a mechanical guarantee. It is not.

A carefully prepared practice may receive one developed proposal, several, or none. An early range may change after assumptions are tested, and a signed LOI may still not become a completed transaction.

Competition also does not make every term attractive. It reveals differences and gives the owner evidence for negotiation, but it cannot force a buyer to accept a term outside that buyer’s mandate.

The honest promise is process discipline. The owner should know who was approached, why each party qualified, what each response meant, and how every proposal compared.

That record is valuable even if the result is “not now.”

The guide to when to sell a veterinary practice explains why timing should remain an owner decision rather than a reaction to one phone call.

What should a veterinary practice owner do next in 2026?

Start by testing readiness, not buyer appetite. Document normalized earnings, doctor coverage, owner dependence, facility assumptions, and the terms that matter personally.

Then decide whether confidential outreach fits your own timing before any buyer sets the process or the terms for you.

If an approach is already on the table, keep it in perspective. It is one data point until its assumptions, structure, and conditions are clear.

If you are earlier, use that space. Clean records and a deliberate buyer thesis can improve decision quality even when you decide not to sell.

We can begin with a free, confidential practice value estimate built around your actual earnings and circumstances. It is an informed starting point, not a promised valuation or sale result.

What matters is leaving the first conversation with sharper questions. A practice owner should never confuse market attention with a finished answer.

---

Frequently asked questions

Does a competitive process guarantee multiple veterinary practice offers in 2026?

No. A competitive process creates an opportunity for qualified buyers to evaluate the same practice, but it cannot guarantee a buyer count, price, timetable, or closing.

Practice quality, buyer fit, and market conditions shape participation.

What makes a veterinary practice buyer qualified?

A qualified buyer has been screened for practice fit, apparent financial capacity, a workable ownership path, confidentiality discipline, and willingness to evaluate the specific veterinary practice. Qualification does not promise an offer or completed transaction.

Is an indication of interest the same as an offer?

No. An indication of interest is preliminary and non-binding, often showing a possible range, structure, and assumptions.

A developed offer provides enough written economic and non-economic terms to compare, though negotiation and diligence remain.

How can a veterinary practice sale stay confidential with several buyers?

The owner can disclose in stages: begin anonymously, screen interested parties, require confidentiality protections, and release identifying details through controlled access. Risk cannot be eliminated, so the buyer list and information flow should remain narrow.

Should I treat an unsolicited approach as a final veterinary practice offer?

No. Treat an unsolicited approach as one market signal, then examine its assumptions and terms.

A stated price alone does not show cash certainty, contingent value, employment obligations, allocation, or another qualified buyer’s view.

How should I compare veterinary practice offers in 2026?

Compare cash at closing, rollover equity, earnout conditions, retained amounts, tax allocation, employment terms, financing assumptions, diligence conditions, and the earnings definition. Ask transaction counsel and tax advisers to review the legal and after-tax consequences.

When does negotiating leverage narrow in a veterinary practice sale?

Leverage narrows when the owner chooses one proposal and accepts restrictions on other buyer conversations. The exact effect depends on the letter of intent, so counsel should identify binding provisions and exit rights before signature.

Are veterinary practice buyers active in 2026?

Capstone Partners counted 18 announced or completed pet-sector transactions through April 10, 2026, versus 8 in the prior-year period; veterinary and health led with 9. That shows activity, not a guarantee for any particular practice.

---

Sources

Industry M&A research and valuation data

1. Capstone Partners. “Pet Sector M&A Update.” April 2026. capstonepartners.com
2. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion; VSOs Under Increasing Pressure.” January 2026. octus.com
3. QuantPillar. “2025-2026 Private Market Valuation Multiples: The Definitive Cheat Sheet.” Q1 2026. quantpillar.com
4. iVET360. “Understanding Your Animal Hospital’s EBITDA.” ivet360.com

Veterinary practice operations, benchmarks, and profession data

5. Frontiers in Veterinary Science. “Making the Case for a Resurgent U.S. Independent Veterinary Practice Segment: A SWOT Analysis.” May 2025. frontiersin.org
6. AVMA. “Benchmarking Data Plus Elevating Efficiency Equals Practice Productivity.” October 2025. avma.org
7. Veterinary Practice News. “From No-Lo Vet Practice to Profits in 7 Steps.” September 2013. veterinarypracticenews.com
8. Vetsource Veterinary Analytics. “Veterinary Industry Summary, October 12-18, 2025.” October 2025. veterinaryanalytics.com
9. AVMA. “Veterinarians Report Increasing Price Sensitivity, Decreasing Visits.” February 2026. avma.org
10. iVET360. “2026 Veterinary Industry Benchmark Report.” April 2026. ivet360.com
11. Frontiers in Veterinary Science. “Career Transition Plans of Veterinarians in Clinical Practice.” July 2024. pmc.ncbi.nlm.nih.gov

Government tax guidance

12. Internal Revenue Service. “About Form 8594, Asset Acquisition Statement Under Section 1060.” March 2026. irs.gov